Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia

Neuroscience

Volumn 66, Issue 2, 1995, Pages 309-319

  Eastwood, S L ^a   Burnet, P W J ^a   Harrison, P J ^a  

^a WARNEFORD HOSPITAL   (United Kingdom)

Author keywords

immunoreactivity; in situ hybridization histochemistry; IR; ISHH

Indexed keywords

HALOPERIDOL; SYNAPTOPHYSIN;

ADOLESCENT; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; FEMALE; GENE EXPRESSION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA;

ANIMAL; BIOLOGICAL MARKERS; FEMALE; GENE EXPRESSION; HALOPERIDOL; HISTOCYTOCHEMISTRY; HUMAN; IN SITU HYBRIDIZATION; MALE; MIDDLE AGE; PYRAMIDAL CELLS; RATS; RNA, MESSENGER; SCHIZOPHRENIA; SUPPORT, NON-U.S. GOV'T; SYNAPSES; SYNAPTOPHYSIN; TEMPORAL LOBE;

EID: 0028965594     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(94)00586-T     Document Type: Article

References (86)

1. Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development
2. A simple dot-immunobinding assay for quantification of synaptophysin-like immunoreactivity in human brain
3. Hippocampal formation
4. Trans-synaptic control of gene expression
5. Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia
6. Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia
7. Pre and post mortem influences on brain RNA
8. Changes of synaptic density in the primary visual cortex of the macaque monkey from fetal to adult stage
9. Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics
10. Synaptic degeneration is the primary neuropathological feature in prion disease: a preliminary study
11. Differential synaptic loss in the cortex in Alzheimer's disease: a study using archival material
12. Temporal lobe asymmetries as the key to the aetiology of schizophrenia
13. Dysmodularity: a neurocognitive model for schizophrenia
14. Hippocampal pathology and memory impairment in Alzheimer's disease
15. Hippocampal synaptophysin gene expression in schizophrenia
16. Striatal synaptophysin expression and haloperidol-induced synaptic plasticity
17. Synaptopysin gene expression in human brain: a quantitative in situ hybridization and immunocytochemical study
18. Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia
19. A quantitative analysis of synaptogenesis in the molecular layer of the dentate gyrus in the monkey
20. Limbic pathology in schizophrenia: the entorhinal region—a morphometric study
21. Cytoarchitectonic and developmenta studies in schizophrenia
22. Schizophrenia caused by a fault in programmed synaptic elimination during
23. Synaptophysin: a probe for the aetiology of schizophrenia
24. Lesions of hippocampal circuitry define synaptosomal-associated protein-25 (SNAP-25) as a novel presynaptic marker
25. Synaptophysin and not rab3A is specifically reduced in the prefrontal cortex of schizophrenic subjects
26. Dual pathways connecting the dorsolateral prefrontal cortex with the hippocampal formation and parahippocampal cortex in the rhesus monkey
27. The neuropsychology of schizophrenia
28. Synaptic loss in Alzheimer's disease and other dementias
29. Cortical cholinergic markers in schizophrenia
30. Effects of neuroleptics on neuronal and synaptic structure
31. On the neuropathology of schizophrenia and its dementia
32. In vitro brain imaging: techniques for studying and localising the pathogenesis of psychiatric diseases
33. Cortical pruning and the development of schizophrenia: a computer model
34. Corticortical connectivity, autonomous networks, and schizophrenia
35. Regional synaptic pathology in Alzheimer's disease
36. Human synaptic proteins with a heterogeneous distribution in cerebellum and visual cortex
37. Hippocampal synaptophysin pathology in patients with temporal lobe epilepsy
38. Synaptic density in the human frontal cortex: developmental changes and effects of aging
39. Prenatal developmental disturbances in the limbic allocortex in schizophrenics
40. The dementia of dementia praecox
41. The distribution of the projection from the hippocampal formation to the nucleus accumbens in the rat—an anterograde and retrograde horseradish peroxidase study
42. Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex—the Feinberg hypothesis revisited
43. Development of synapses and neurites of hippocampal and cortical neurons for up to 6 months in culture: estimation of the number of synapses by ELISA
44. A neurohistological correlate of schizophrenia
45. Synaptic pathology in Alzheimer's disease: immunologic data for markers of synaptic and large dense-core vesicles
46. Expression of the synaptophysin gene family is not restricted to neuronal and neuroendocrine differentiation in rat and human
47. Chromatin structure, gene expression, and nuclear aluminium in Alzheimer's disease
48. Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer's disease
49. Quantitative immunohistochemistry of synaptophysin in human neocortex: an alternative method to estimate density of presynaptic terminals in paraffin sections
50. Cortical and subcortical patterns of synaptophysin-like immunoreactivity in Alzheimer's disease
51. The role of the synaptic proteins in the pathogenesis of disorders of the central nervous system
52. Quantitative synaptic alterations in the human neocortex during normal aging
53. Synaptic and neuritic alterations during the progression of Alzheimer's disease
54. Excitotoxicity and selective neuronal loss in epilepsy
55. Dynamics of synapsin I gene expression during the establishment and restoration of functional synapses in the rat hippocampus
56. Electron microscope study on schizophrenia: mechanism of pathological changes
57. Synaptogenesis in the rat suprachiasmatic nucleus demonstrated by electron microscopy and synapsin immunoreactivity
58. A neurodevelopmental approach to the classification of schizophrenia
59. Plasticity of neuronal connections in developing brains of mammals
60. Light and electron microscopic analysis of synaptic development in Macaca monkey retina as detected by immunocytochemical labelling for the synaptic vesicle protein, SV2
61. Ultrastructural features of biopsied temporopolar cortex (area 38) in a case of schizophrenia
62. 31P nuclear magnetic resonance spectroscopy: neurodevelopment and schizophrenia
63. Cortical synaptic membrane protein immunoreactivity in schizophrenia contrasts with Alzheimer's disease
64. Severe cognitive impairment in elderly schizophrenic patients: a clinico-pathological study
65. Schizophrenia: a neuropathological perspective
66. The synaptic organization of the human striatum in schizophrenics and controls a quantitative ultrastructural study
67. Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid β/A4 protein precursor
68. Decreased synaptic density in aged brains and its prevention by rearing under enriched environment as revealed by synaptophysin contents
69. Social class, marriage and fertility in schizophrenia
70. Neuropsychological function in schizophrenia: selective impairment in memory and learning
71. Ultrastructure of cortical synapses in the brain of schizophrenics
72. Altered GAP-43 and synaptophysin levels in visual association cortices in schizophrenic brains
73. Abnormal synaptic reinnervation as the basis of schizophrenia. A hypothesis
74. Ultrastructural morphometric analysis of lipofuscin in pyramidal cells of the human Ammon's horn
75. Synapsin I, synapsin II, and synaptophysin: marker proteins of synaptic vesicles
76. Cholecystokinin-immunoreactive boutons in synaptic contact with hippocampal pyramidal neurons that project to the nucleus accumbens
77. Extrinsic projections from area CA1 of the rat hippocampus: olfactory, cortical, subcortical and bilateral hippocampal formation projections
78. Quantitation of nerve terminal populations: synaptic vesicle-associated proteins as markers for synaptic density in the rat neostriatum
79. Implications of normal brain development for the pathogenesis of schizophrenia
80. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease
81. Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles
82. Laminar and region-specific cell surface markers in the entorhinal cortex and hippocampus
83. Regional differentiation of cell densities in left and right hippocampi of epileptic patients
84. Quantitative assessment of the synaptophysin immunoreactivity of the cortical neuropil in various neurodegenerative disorders with dementia
85. Synaptophysin immunoreactivity of the cortical neuropil in vascular dementia of Binswanger type compared with Alzheimer type and nondemented controls